Inventor

VAN DIJK MARC

NL42 patents

⚠️ This page may combine multiple inventors who share the name “VAN DIJK MARC”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VAN DIJK MARC

AGENUS INC

Anti-GITR antibodies and methods of use thereof

Anti-OX40 antibodies

Anti-GITR antibodies and methods of use thereof

Anti-TIM-3 antibodies and methods of use thereof

Anti-CTLA-4 antibodies and methods of use thereof

Anti-CTLA-4 antibodies and methods of use thereof

Anti-CD137 antibodies and methods of use thereof

Antibodies and methods of use thereof

Anti-CTLA-4 antibodies and methods of use thereof

Anti-PD-1 antibodies and methods of use thereof

Anti-CTLA-4 antibodies and methods of use thereof

Anti-CTLA-4 antibodies and methods of use thereof

Anti-TIM-3 antibodies and methods of use thereof

Nucleic acids encoding anti-OX40 antibodies

Anti-GITR antibodies and methods of use thereof

Anti-CTLA-4 antibodies and methods of use thereof

Anti-PD-1 antibodies and methods of use thereof

Vectors comprising nucleic acids encoding anti-OX40 antibodies

Anti-GITR antibodies and methods of use thereof

Antibodies and methods of use thereof

Methods of administering anti-OX40 antibodies

Antibodies and methods of use thereof

Anti-OX40 antibodies

Anti-LAG-3 antibodies and methods of use thereof

Anti-LAG-3 antibodies and methods of use thereof

Anti-GITR antibodies and methods of use thereof

Anti-CTLA-4 antibodies and methods of use thereof

Anti-GITR antibodies and methods of use thereof

Anti-CD137 antibodies and methods of use thereof

Anti-CTLA-4 antibodies and methods of use thereof

Anti-LAG-3 antibodies and methods of use thereof

Anti-lag-3 antibodies and methods of use thereof

Anti-GITR antibodies and methods of use thereof

Anti-OX40 antibodies and anti-GITR antibodies

Anti-CD137 antibodies and methods of use thereof

Anti-TIM-3 antibodies and methods of use thereof

Anti-TIM-3 antibodies and methods of use thereof

Anti-PD-1 antibodies and methods of use thereof

MINK THERAPEUTICS INC

T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof

Engineered host cells and methods of use thereof

T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof

T cell receptors that bind to NY-ESO-1 and methods of use thereof